Safety and Pharmacokinetics of Casirivimab and Imdevimab (CAS+IMD) in Pediatric Outpatients With COVID-19.
Norton TD, Thakur M, Ganguly S, Ali S, Chao J, Waldron A, Xiao J, Turner KC, Davis JD, Irvin SC, Pan C, Atmodjo D, Hooper AT, Hamilton JD, Hussein M, Subramaniam D, Roque-Guerrero L, Kohli A, Mylonakis E, Geba GP, Cox E, Braunstein N, Dakin P, Kowal B, Bhore R, DiCioccio AT, Hughes D, Herman GA; Trial Investigators.
Norton TD, et al. Among authors: hamilton jd.
J Pediatric Infect Dis Soc. 2024 Oct 1:piae105. doi: 10.1093/jpids/piae105. Online ahead of print.
J Pediatric Infect Dis Soc. 2024.
PMID: 39351798